These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30657044)

  • 1. Implantable Cardioverter-Defibrillators in Patients with ESRD: Complications, Management, and Literature Review.
    Mehdi B; Kaveh H; Ali VF
    Curr Cardiol Rev; 2019; 15(3):161-166. PubMed ID: 30657044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased complication rates of cardiac rhythm management devices in ESRD patients.
    Dasgupta A; Montalvo J; Medendorp S; Lloyd-Jones DM; Ghossein C; Goldberger J; Passman R
    Am J Kidney Dis; 2007 May; 49(5):656-63. PubMed ID: 17472848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation.
    Aggarwal A; Wang Y; Rumsfeld JS; Curtis JP; Heidenreich PA;
    Heart Rhythm; 2009 Nov; 6(11):1565-71. PubMed ID: 19879533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
    Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
    Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.
    Pun PH; Hellkamp AS; Sanders GD; Middleton JP; Hammill SC; Al-Khalidi HR; Curtis LH; Fonarow GC; Al-Khatib SM
    Nephrol Dial Transplant; 2015 May; 30(5):829-35. PubMed ID: 25404241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
    Charytan DM; Patrick AR; Liu J; Setoguchi S; Herzog CA; Brookhart MA; Winkelmayer WC
    Am J Kidney Dis; 2011 Sep; 58(3):409-17. PubMed ID: 21664735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.
    Vriesendorp PA; Schinkel AF; Van Cleemput J; Willems R; Jordaens LJ; Theuns DA; van Slegtenhorst MA; de Ravel TJ; ten Cate FJ; Michels M
    Am Heart J; 2013 Sep; 166(3):496-502. PubMed ID: 24016499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillators with end stage renal disease: Nationwide inpatient sample database results.
    Ayoub K; Fry E; Marji M; Masri A; Hesselson A; Ellison K
    Pacing Clin Electrophysiol; 2022 Jan; 45(1):124-131. PubMed ID: 34806769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiencies and Complications of Dual Chamber versus Single Chamber Implantable Cardioverter Defibrillators in Secondary Sudden Cardiac Death Prevention: A Meta-analysis.
    Hu ZY; Zhang J; Xu ZT; Gao XF; Zhang H; Pan C; Chen SL
    Heart Lung Circ; 2016 Feb; 25(2):148-54. PubMed ID: 26338316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease and mortality in implantable cardioverter-defibrillator recipients.
    Cheema A; Singh T; Kanwar M; Chilukuri K; Maria V; Saleem F; Johnson K; Frank J; Pires L; Hassan S
    Cardiol Res Pract; 2010 Aug; 2010():. PubMed ID: 20811610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular implantable electronic devices in hemodialysis patients: an updated review.
    Spatola L; Rivera RF; Migliore F; Bilato C; Mugnai G
    J Cardiovasc Med (Hagerstown); 2021 Dec; 22(12):867-873. PubMed ID: 34009181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients.
    Robin J; Weinberg K; Tiongson J; Carnethon M; Reddy M; Ciaccio C; Quadrini M; Hsu J; Fan J; Choi P; Kadish A; Goldberger J; Passman R
    Heart Rhythm; 2006 Oct; 3(10):1196-201. PubMed ID: 17018351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention.
    Ascoeta MS; Marijon E; Defaye P; Klug D; Beganton F; Perier MC; Gras D; Algalarrondo V; Deharo JC; Leclercq C; Fauchier L; Babuty D; Bordachar P; Sadoul N; Boveda S; Piot O;
    Heart Rhythm; 2016 May; 13(5):1045-1051. PubMed ID: 26749313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators.
    Herzog CA; Li S; Weinhandl ED; Strief JW; Collins AJ; Gilbertson DT
    Kidney Int; 2005 Aug; 68(2):818-25. PubMed ID: 16014061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.
    El-Chami MF; Levy M; Kelli HM; Casey M; Hoskins MH; Goyal A; Langberg JJ; Patel A; Delurgio D; Lloyd MS; Leon AR; Merchant FM
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):900-904. PubMed ID: 25952566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
    Koman E; Gupta A; Subzposh F; Saltzman H; Kutalek SP
    J Interv Card Electrophysiol; 2016 Mar; 45(2):219-23. PubMed ID: 26768264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of implantable cardioverter defibrillator recipients with end-stage renal disease.
    El-Chami MF; Matar L; Smith P; Casey M; Addish MA; Kelly K; Wood C; Merlino J; Goyal A; Leon AR; Merchant FM
    J Arrhythm; 2017 Oct; 33(5):459-462. PubMed ID: 29021850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease and implantable cardioverter defibrillator related complications: 16 years of experience.
    Buiten MS; DE Bie MK; VAN DER Heijden AC; Rotmans JI; Bootsma M; Marc Groeneveld JH; Wolterbeek R; Rabelink TJ; Jukema JW; Schalij MJ; VAN Erven L
    J Cardiovasc Electrophysiol; 2014 Sep; 25(9):998-1004. PubMed ID: 24758287
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.